Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function

Código QR

Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function

Kenji Takeyoshi,1,2 Masatake Kurita,1–3 Satoshi Nishino,2,3 Mika Teranishi,1 Yukio Numata,2 Tadahiro Sato,2 Yoshiro Okubo11Department of Psychiatry and Behavioral Science, Graduate School of Medicine, Nippon Medical School, Bunkyo-ku, Tokyo, 2Sato Hospital, Koutokukai, Nanyo, Yamagata, 3De...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Takeyoshi K, Kurita M, Nishino S, Teranishi M, Numata Y, Sato T, Okubo Y
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	herbal medicine MHPG homovanillic acid HVA noradrenaline BPSD Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/8d8f0286fefe4a3d920c5cd3a4c2d088
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Noradrenaline plays a critical role in the switch to a manic episode and treatment of a depressive episode
por: Kurita M
Publicado: (2016)

Effectiveness and Safety of Aromatherapy in Managing Behavioral and Psychological Symptoms of Dementia: A Mixed-Methods Systematic Review
por: Becky Siu Yin Li, et al.
Publicado: (2021)

Need for medication to complement catecholamines in smoking cessation of hardcore smokers
por: Kawai A, et al.
Publicado: (2017)

Precision Medicine of Sodium Benzoate for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)
por: Lin CH, et al.
Publicado: (2020)

Effectiveness of online cognitive behavioral therapy on family caregivers of people with dementia
por: Kwok T, et al.
Publicado: (2014)

Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease
por: Mannu P, et al.
Publicado: (2011)

The noradrenaline metabolite MHPG is a candidate biomarker between the depressive, remission, and manic states in bipolar disorder I: two long-term naturalistic case reports
por: Kurita M, et al.
Publicado: (2015)

The Psychiatric Misdiagnosis of Behavioral Variant Frontotemporal Dementia in a Colombian Sample
por: Lina Zapata-Restrepo, et al.
Publicado: (2021)

Management of the behavioral and psychological symptoms of dementia
por: Elizabeth C Hersch, et al.
Publicado: (2008)

New Users of Herbal Medicine Containing Aristolochic Acids and the Risk of Dementia in the Elderly: A Nationwide, Population-Based Study in Taiwan
por: Chiou YE, et al.
Publicado: (2020)

Does early improvement in depressive symptoms predict subsequent remission in patients with depression who are treated with duloxetine?
por: Sueki A, et al.
Publicado: (2016)

Risk factors for suicide among patients with schizophrenia: a cohort study focused on cerebrospinal fluid levels of homovanillic acid and 5-hydroxyindoleacetic acid
por: Neider D, et al.
Publicado: (2016)

COMPARISON OF EFFICACY ON NORADRENALINE AND TERLIPRESSIN IN HEPATORENAL SYNDROME IN THE PATIENTS OF DECOMPENSATED CIRRHOSIS – A RANDOMIZED CONTROLLED STUDY
por: Muhammad Siddique, et al.
Publicado: (2019)

The Mammalian Locus Coeruleus Complex—Consistencies and Variances in Nuclear Organization
por: Paul R. Manger, et al.
Publicado: (2021)

Anorexia nervosa depends on adrenal sympathetic hyperactivity: opposite neuroautonomic profile of hyperinsulinism syndrome
por: Lechin F
Publicado: (2010)

Hashimoto encephalopathy with high plasma monoamine metabolite levels: a case report
por: Horikoshi S, et al.
Publicado: (2017)

Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder
por: Ichinose M, et al.
Publicado: (2021)

DA-9805 protects dopaminergic neurons from endoplasmic reticulum stress and inflammation
por: Sora Kang, et al.
Publicado: (2022)

Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review
por: Masopust J, et al.
Publicado: (2018)

Yokukansan and its ingredients as possible treatment options for schizophrenia
por: Yu CH, et al.
Publicado: (2014)

Antidopaminergic medication in healthy subjects provokes subjective and objective mental impairments tightly correlated with perturbation of biogenic monoamine metabolism and prolactin secretion
por: Veselinović T, et al.
Publicado: (2018)

Thermal Vision Examination of Vasoconstriction and Vasodilatation of Blood Vessels under the Influence of Local Anesthetic Solutions
por: Đukić Igor, et al.
Publicado: (2018)

Current Treatment Options for REM Sleep Behaviour Disorder
por: Félix Javier Jiménez-Jiménez, et al.
Publicado: (2021)

Neuromolecular Underpinnings of Negative Cognitive Bias in Depression
por: Karolina Noworyta, et al.
Publicado: (2021)

Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse
por: Sternat T, et al.
Publicado: (2016)

Pain as a challenge in nursing home residents with behavioral and psychological symptoms of dementia
por: Nowak T, et al.
Publicado: (2018)

Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease
por: Yoshiyuki Kagawa, et al.
Publicado: (2021)

Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
por: MA Qamar, et al.
Publicado: (2017)

Inhibitory effect of the Kampo medicinal formula Yokukansan on acute stress-induced defecation in rats
por: Kanada Y, et al.
Publicado: (2018)

Antistress effects of Kampo medicine "Yokukansan" via regulation of orexin secretion
por: Katahira H, et al.
Publicado: (2017)

Plasma levels of IL-6 in patients with untreated major depressive disorder: comparison with catecholamine metabolites
por: Yoshimura R, et al.
Publicado: (2019)

Relevance of deprivation studies in understanding rapid eye movement sleep
por: Mehta R, et al.
Publicado: (2018)

A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
por: Zhong Z, et al.
Publicado: (2017)

Non-24-hour sleep–wake syndrome improved by low-dose valproic acid: a case report
por: Kurita M, et al.
Publicado: (2016)

Obesity-Related Glomerulopathy: From Mechanism to Therapeutic Target
por: Wei L, et al.
Publicado: (2021)

"Hierba del Clavo" (Geum chiloense) interfiere niveles de ciclosporina: Potencial riesgo para trasplantados
por: Duclos H,Jaime, et al.
Publicado: (2001)

Divya-Herbal-Peya Decoction Harmonizes the Inflammatory Response in Lipopolysaccharide-Induced Zebrafish Model
por: Balkrishna A, et al.
Publicado: (2021)

Two cases of Alzheimer&#39;s disease showing deterioration of behavioral and psychological symptoms of dementia induced by switching from rivastigmine to donepezil
por: Kimura T, et al.
Publicado: (2012)

A non-pharmacological intervention to manage behavioral and psychological symptoms of dementia and reduce caregiver distress: Design and methods of project ACT3
por: Laura N Gitlin, et al.
Publicado: (2008)

Review of herbal medicine works in the avian species
por: Tyagita Hartady, et al.
Publicado: (2021)